Triton to take UK pharmaceutical firm Clinigen private in a £1.2bn deal | AltAssets Private Equity News
Summary
It picked up after Triton made its offer and share prices rose to 900 pence after the agreement was announced. Triton said the Company performs an important role in providing medicines around the world for patients with unmet needs through working directly with healthcare professionals and regulators, highlighting its broad reach and diverse capabilities. Triton recognises the potential Clinigen holds in growing its offering in the global pharmaceutical ecosystem. It agreed to sell German radiology and radiotherapy player Meine Radiologie to EQT Infrastructure in July after seeing turnover surge at the company since its 2019 buyout. Triton closed its fifth main buyout vehicle on €5.2bn in 2018, smashing its €4bn target and beating its hard cap.